Cigna (CI) 8-K Current Report: March 3, 2026
Filed: March 3, 2026
Financials
Hospital & Medical Service PlansCigna (CI) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
Cigna 8-K Mar 3, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Brian Evanko, 49, named CEO effective July 1, 2026; succeeds David Cordani, who becomes Executive Chair
- • Evanko total target compensation: $1.3M base salary + $2.6M EIP + $15.1M LTI annually
- • One-time transitional equity award of $3.5M granted to Evanko upon CEO assumption
- • Cordani's post-retirement pay: $1.0M base + $2.0M EIP; retains LTI eligibility as Executive Chair
- • Planned succession with long internal tenure — Evanko has held CFO, COO, and divisional CEO roles since 2013
Item 7.01 · Regulation FD Disclosure
- • 2026 EPS guidance reaffirmed at ≥$30.25 adjusted income from operations per share
- • Evernorth segment 2026 pre-tax adjusted income reaffirmed at ≥$6.9B
- • Cigna Healthcare segment 2026 pre-tax adjusted income reaffirmed at ≥$4.5B
- • Reaffirmation signals management confidence despite healthcare sector macro pressures (cost inflation, regulatory risk, drug pricing)
Other Cigna 8-K Filings
Get deeper insights on Cigna
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.